IP Library Granted Patent US 8,221,659
Granted Patent B2
US 8,221,659 · App. 13/231,500 · Granted Jul 17, 2012

Method and apparatus for the dry release of a compliant ophthalmic article from a mold surface

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,659
App. No.
13/231,500
Granted
Jul 17, 2012
Kind
B2
Abstract

An apparatus for releasing a molded lens from a deformable mold includes a shear ring for temporarily retaining an annular portion of the deformable mold outside a periphery of the lens and a plunger for deforming an annular section of the deformable mold within the periphery of the lens. The apparatus can be employed to release a non-hydrated hydrogel lens from a deformable mold section.

Claims (17)

1. A method for releasing an ophthalmic molded lens from a mold cavity of a deformable mold, the deformable mold having an anterior molding surface and an opposite curved posterior surface, the method comprising:

a) distorting the anterior molding surface by

i) pressing against the curved posterior surface along a first annulus; and

ii) pressing against the anterior molding surface along a second annulus comprising a shear ring;

b) the first and second annuli being generally concentric with the molded lens with the first annulus being within a perimeter of the molded lens and the second annulus being radially spaced from the perimeter of the molded lens; and

c) the distorting of the molding surface creating sufficient shear between the molded lens and the molding surface to effect a peeling of the molded lens from the molding surface.

2. The method of claim 1 , wherein the peeling progresses radially inward from the perimeter of the molded lens.

3. The method of claim 1 , wherein pressing against the curved posterior surface is continuous along the first annulus.

4. The method of claim 1 , further comprising forming the first annulus of a rounded surface.

5. The method of claim 1 , wherein pressing against the curved posterior surface is intermittent along the first annulus.

6. The method of claim 1 , wherein pressing against the anterior molding surface is continuous along the second annulus.

7. The method of claim 1 , wherein pressing against the anterior molding surface is intermittent along the second annulus.

8. The method of claim 1 , further comprising forming the shear ring to include a knife edge.

9. The method of claim 8 , further comprising forming the knife edge from facets intersecting at an acute included angle.

10. The method of claim 8 , further comprising forming the knife edge from facets intersecting at an obtuse included angle.

11. The method of claim 1 , further comprising hydrating the molded lens after peeling of the molded lens from the molding surface.

12. The method of claim 1 , further comprising releasing an ophthalmic molded lens having a hydrated modulus less than 70 gm/mm 2 .

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 15, 2012
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028788/0271 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →